Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies

Pancreatic ductal adenocarcinoma is an extremely aggressive disease with a high metastatic potential. Most patients are diagnosed with metastatic disease, at which the five-year survival rate is only 3%. A better understanding of the mechanisms that drive metastasis is imperative for the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayres Pereira, Marina, Chio, Iok In Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016631/
https://www.ncbi.nlm.nih.gov/pubmed/31861620
http://dx.doi.org/10.3390/genes11010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016631/
https://www.ncbi.nlm.nih.gov/pubmed/31861620
http://dx.doi.org/10.3390/genes11010006

Ejemplares similares